Colorectal cancer (CRC) represents the third most commonly diagnosed cancer and the
second leading cause of cancer death worldwide. The modern concept of cancer biology …

Cell cycle, growth, survival and metabolism are tightly regulated together and failure in
cellular regulation leads to carcinogenesis. Several signaling pathways like the PI3K, WNT …

Accumulating evidence has demonstrated that cancer stem cells (CSCs) play an essential
role in tumor progression and reoccurrence and drug resistance. Multiple signaling …

Chemoresistance and development of relapses are ascribable to a rare cell population of
tumour mass: cancer stem cells (CSCs). Targeting CSCs could increase patients' survival …

Approximately 80% of human bladder cancers (BC) are non-muscle invasive when first
diagnosed and are usually treated by transurethral tumor resection. But 50–80% of patients …

Colorectal cancer (CRC) is a common neoplastic disease and a frequent cause of death.
Drug resistance is a major challenge to CRC treatment and stem-like side-population (SP) …

Since their discovery, cancer stem cells have become a hot topic in cancer therapy research.
These cells possess stem cell-like self-renewal and differentiation capacities and are …

Cervical cancer (CaCx) poses a significant global health challenge, ranking as the fourth
most common cancer among women worldwide. Despite the emergence of advanced …

Colorectal cancer (CRC) recurrence is often attributable to circulating tumor cells and/or
cancer stem cells (CSCs) that resist to conventional therapies and foster tumor progression …

Despite being largely preventable through early vaccination and screening strategies,
cervical cancer is the most common type of gynecological malignancy worldwide and …